Articles

Subject access requests (SARs) continue to pose significant challenges for organisations in the pharmaceuticals and life sciences sector. They are often time-consuming, resource-intensive and frequently linked to wider complaints or disputes. This article shares some practical tips to help organisations manage SARs effectively.

The DUAA progress statement provides useful insights on regulation of AI, so that businesses can proactively address risk.

After much uncertainty and concern, finally some incredibly positive news for the UK life sciences sector.  

As we look ahead to 2026, the property industry in England and Wales is set to face a range of legislative and regulatory changes. These reforms will have a significant impact on both the residential and commercial property sectors. Below, we outline some of the most important changes expected to influence the market in the coming year.

Revised legislation reallocates PAYE risk within labour supply chains and expands anti-avoidance provisions. 

The UK anti-corruption strategy 2025 confirms that reform of employment whistleblowing protections is under active consideration.